(Cell Metabolism 27, 136–150; January 9, 2018)
In the originally published article, in the Key Resources Table, “Leptin neutralizing antibody: Mouse monoclonal anti-LEPR; R&D Systems, Inc.; Cat# AF497” was incorrectly listed. This entry should have been: “Leptin neutralizing antibody: Polyclonal Goat anti-mouse Leptin antibody; R&D Systems, Inc.; Cat# AF498; RRID: AB_355394.” In addition, under Experimental Model and Subject Details, MMTV-PyMT (PyMT)/B6 (Davie et al., 2007) mice were kindly provided by Dr. Lesley G. Ellies (University of California, San Diego); they were not purchased from the Jackson Laboratory. Both of these changes have now been made online and do not affect the results or conclusions of the study. The authors would like to apologize for any inconvenience this may have caused.
References
- Davie SA, Maglione JE, Manner CK, Young D, Cardiff RD, MacLeod CL, Ellies LG. Effects of FVB/NJ and C57Bl/6J strain backgrounds on mammary tumor phenotype in inducible nitric oxide synthase deficient mice. Transgenic Res. 2007;16:193–201. doi: 10.1007/s11248-006-9056-9. [DOI] [PMC free article] [PubMed] [Google Scholar]